Aim Previous research has indicated an association between diabetes and anxiety. However, no synthesis has determined the direction of this association. The aim of this study was to determine the longitudinal relationship between anxiety and diabetes.
Introduction
The prevalence of diabetes is increasing, with current estimates projecting that 642 million people worldwide will have diabetes by 2040 [1] . As the prevalence of diabetes increases there is interest in identifying modifiable diabetes risk factors that could be targeted by interventions to reduce this projected increase. Alongside this, there is also interest in reducing the burden of diabetes in people who already have the condition by identifying modifiable risk factors associated with poorer health outcomes. Poor mental health has been identified as a potentially modifiable risk factor associated with an increased risk of both developing diabetes and poorer outcomes in people who have diabetes [2, 3] . Therefore, there is interest in how mental illness and diabetes are linked.
Anxiety disorders are a group of mental disorders characterized by feelings of anxiety and fear that significantly impact the social and occupational functioning of individuals [4] . They are among some of the most prevalent mental disorders in the population, affecting up to 30% of adults [5, 6] . Furthermore, anxiety disorders are one of the leading causes of disability worldwide [7] and are associated with a poorer quality of life [8] . Alongside their immediate impact on mental health and functioning, there is also evidence that symptoms of anxiety and anxiety disorders might be associated with an increased risk of developing non-communicable diseases such as heart disease [9] . It is possible that anxiety could lead to diabetes as it shares strong associations with many of the acknowledged risk factors for diabetes such as overweight/obesity [10] , cardiometabolic abnormalities [11] , unhealthy lifestyle behaviours [12] and sleep disturbance [13] . However, data on anxiety as a risk factor for incident diabetes has not yet been synthesized, so it is unclear whether anxiety itself is an independent risk factor for the development of diabetes.
Previous research indicates that people with diabetes have a greater likelihood of developing mental health problems such as depression [14] . It is possible that biological changes induced by diabetes [15] alongside lifestyle limitations and feelings related to living with a serious chronic illness [16] could all be linked with poorer mental health. However, there is no synthesis that tells us whether diabetes might be linked with a greater risk of developing anxiety. Previous metaanalyses and systematic reviews indicate that people with diabetes have an increased likelihood of concurrent anxiety [17, 18] , however we do not know if diabetes is associated with an increased risk of developing incident anxiety.
The aim of this review was to determine the longitudinal association between diabetes and anxiety by systematically searching for and reviewing studies that investigated either anxiety as a risk factor for incident diabetes in adults aged 16 or older or diabetes as a risk factor for incident anxiety in adults aged 16 or older.
Methods

Search strategy
A systematic literature search was conducted by KS and SD between January 2017 and August 2017. The study protocol was registered on PROSPERO (protocol ID: CRD420170 56775; https://www.crd.york.ac.uk/PROSPERO). There were no restrictions on publication date or language, although only English and French language studies were reviewed. Search terms relating to synonyms of 'anxiety' and 'diabetes' (see Doc. S1) were searched in seven databases including PubMed (United States National Library of Medicine, Bethesda, MD, USA), SCOPUS (Elsevier, Amsterdam, Netherlands), EMBASE (Elsevier), ISI Web of Knowledge (Thomson Reuters, New York, NY, USA), PsychINFO (American Psychological Association, Washington DC, USA), CINAHL (Elsevier) and ProQuest (Dissertations and Theses; conference papers index and Nursing and Allied Health) (ProQuest, Ann Arbour, MI, USA).
Further to this, hand searches were undertaken within relevant conference proceedings and journals (see Supporting Information Doc. S1). The bibliographies of relevant reviews on anxiety and diabetes [17] [18] [19] were also searched.
Study selection
For the direction of anxiety to incident diabetes, eligible studies were prospective studies that assessed the incidence of diabetes in people aged 16 or over who were assessed for the presence of anxiety at baseline. To examine diabetes to incident anxiety, studies were required to be prospective studies that assessed the incidence of anxiety in people aged 16 or over who were assessed for the presence of diabetes at baseline. Only studies that examined Type 1 and/or Type 2 diabetes were included. Included studies were required to assess anxiety symptoms (as defined by elevated anxiety symptoms on a validated scale) or anxiety disorders (as assessed by diagnostic interview or clinical diagnosis). In this review, anxiety was defined as the anxiety disorders included in Diagnostic and Statistical Manual (DSM) version IV or V; version V excludes post-traumatic stress disorder (PTSD) and obsessive-compulsive disorder (OCD) whereas version IV includes these disorders. For both research questions, exclusion criteria included a cross-sectional study design, studies that did not assess incidence (i.e. did not control for baseline levels of the outcome) and those that explicitly assessed gestational diabetes. There were no restrictions set on the type of population included.
Two authors (KS and SD) independently screened all studies for these criteria (see Fig. 1 ), and disagreements were resolved by consensus or, where necessary, a third author (NS). Studies that were shortlisted after full-text assessment were put forward for data extraction and quality assessment.
Data extraction and quality assessment
Data extraction and quality assessment were completed independently by two authors (KS and SD) with disagreements resolved by consensus. The following characteristics were extracted from eligible studies: author (date), study characteristics (name, country, number of participants), sample characteristics (% female, ethnicity and age), anxiety measurement (name of measure, information regarding type of anxiety assessed), diabetes measurement, outcome information (follow-up length, % developed outcome), statistical analysis (type of statistical test and confounders controlled for) and measures of association (unadjusted and/or mostadjusted estimate).
Quality assessment was performed using two tools: the Newcastle-Ottawa Scale (NOS) [20] and the Risk Of Bias In
What's new?
• This is the first synthesis to determine the direction of association between anxiety and diabetes.
• The results indicate that anxiety is a risk factor for incident diabetes.
• The results also indicate that there is a need for further research into diabetes as a risk factor for incident anxiety.
Non-randomized Studies of Interventions (ROBINS-I) [21] . We opted to use both tools because the NOS offers a good overview of study methodology and representativeness, whereas the ROBINS-I offers a more comprehensive assessment of bias. The following characteristics were assessed using the NOS: representativeness of sample (community sample), selection of controls (same population as sample), measure of predictor and outcome (validated measurements), demonstration that outcome not present at start of study, length of follow-up (≥ 5 years), adequacy of follow-up participation rate (> 60%), inclusion of at least three important confounders and if the study controlled for the most important confounder (metabolic abnormalities). Studies were assessed on a star system whereby they were given one star for each criterion met. Possible scores ranged from 0 to 9, with higher scores being indicative of better study quality. See Table S1 for NOS quality assessment. Use of the ROBINS-I requires pre-identification of the most important confounders to assess bias. For the present review assessing the direction of anxiety to diabetes, the most important confounders were determined to be sociodemographic characteristics (e.g. age, sex, ethnicity, education, income) and cardiometabolic abnormalities (e.g. adiposity, blood pressure, inflammation, cholesterol, triglycerides). For the direction of diabetes to anxiety, the most important confounders were determined to be sociodemographic characteristics and other chronic conditions. Choice of confounders was based on these variables sharing a potentially explanatory association between the relevant predictor and outcome [10, 11, 18] . The ROBINS-I assessed studies on the following characteristics: bias due to confounding, bias in selection of participants into study, bias due to deviations from intended interventions, bias due to missing data, bias in measurement of outcomes and bias in selection of the reported result. Following the assessment of bias in each domain the authors independently judged the overall risk of bias as: critical, serious, moderate or low. See Table S2 for the ROBINS-I quality assessment.
In addition to the quantitative quality assessments, both screening authors also undertook a qualitative quality assessment to independently determine the main strengths and limitations of each included study.
Meta-analysis
Eligible data were entered into a random-effects metaanalysis because this provides more conservative estimates allowing for more heterogeneity between studies. If studies Full-text articles assessed for eligibility: (n = 124)
Full-text articles excluded:
Did not assess diabetes (n = 26) Study duplication (n = 7) Did not assess anxiety (n = 22) Cross-sectional study (n = 11) No data on incidence (n = 13) Age of population (n = 3) No full-text access (n = 7) Study language (n = 1) Reference group not free predictor (n = 7) No reference group (n = 2) Non-observation study (n = 8)
Studies included in qualitative synthesis:
Studies included in quantitative synthesis (meta-analysis) (n = 13 least adjusted; n = 14 most adjusted) provided stratified analyses for their predictor (e.g. analyses stratified by gender) these were first combined into a single estimate. We then plotted the least adjusted (unadjusted or adjusted for age only) association, followed by the most adjusted. For the least adjusted association, we either used odds ratios (ORs; unadjusted or adjusted for age only) or calculated the OR using raw event data. For each association, we performed a series of sensitivity analyses to assess the impact of methodological study differences (e.g. population studied, confounders controlled for, anxiety assessment) on the strength of the associations.
Alongside the meta-analyses we determined statistical heterogeneity for each analysis by calculating the inconsistency (I 2 ) index (scores of 25%, 50% and 75% indicate low, moderate and high heterogeneity, respectively). Publication bias was assessed by visual inspection of funnel plots and Egger's test, with symmetric funnel plots and a nonsignificant Egger's test being indicative of no publication bias. All analyses were performed with Comprehensive Meta-Analysis 3.0 (Biostat, Englewood, NJ, USA).
Results
Study selection
In total, 5418 studies were found after excluding duplicates (Fig. 1) . After applying broad screening criteria, 5295 studies were excluded. The main reasons for excluding studies were that they did not assess the predictor or outcome of interest, the study was conducted in a non-human population, language restrictions or that the study was cross-sectional. A total of 124 studies were put forward for full-text analysis, following which 108 were excluded. Reasons for exclusion were that the study did not assess incidence of diabetes or anxiety, the study was a poster presentation with no full-text access for data extraction, the study was cross-sectional and the study did not perform the analysis required for inclusion in this review. Inter-rater reliability for study screening was good (kappa = 0.72).
Of the remaining 16 studies, 14 examined the direction of association from anxiety to incident diabetes and two examined the direction of association from diabetes to incident anxiety. Table 1 summarizes the characteristics of the studies. Table 2 summarizes the quality assessments performed for all studies along with a qualitative synthesis of the main study strengths and weaknesses as identified by the reviewers (for the full quality assessment tables see Tables S1  and S2 ). Most studies (n = 11) were from North America [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] , with an additional three studies from Europe [33] [34] [35] , one from Asia [36] and one from the Middle-East [37] .
Because of the small number of studies examining diabetes to anxiety (n = 2) we put forward only those studies examining anxiety to diabetes for the quantitative synthesis (n = 14).
Study review
Anxiety to incident diabetes
In the 14 studies that examined the association between anxiety and incident diabetes, 115 418 people from a total of 1 760 800 (6.6%) developed incident diabetes ( Table 1) . Seven of the ten studies that provided an unadjusted or minimally adjusted estimate reported a significant association between baseline anxiety and incident diabetes [23] [24] [25] 27, 30, 31, 33] . Of the 13 studies that examined the most adjusted association between baseline anxiety and incident diabetes, eight found a significant association [23, 25, 27, 28, 30, 31, 35, 36] . Overall study quality was variable with 10 studies having low or moderate evidence of bias (see Table 2 ) and four having some serious bias issues [26, 33, 35, 37] . In studies identified as having serious bias, bias was due to issues with adjustment for confounders, lack of transparency in reporting and participant sampling ( Table 2) .
Of the seven studies that found a significant least adjusted association between baseline anxiety and incident diabetes, two examined general anxiety symptoms [24, 33] . Atlantis et al. [33] found that for every 10-point increase in the Beck Anxiety Index score there was a 1.6-fold increase in the odds of developing incident diabetes over 2 years. However, they did not provide an adjusted estimate. Demmer et al. [24] found that in women only, high anxiety symptoms as measured with the General Well-Being Scale were associated with a 2.15 times increased likelihood of developing diabetes over 17 years. However, this association was attenuated after adjustment for sociodemographics, BMI and lifestyle characteristics, and no association between anxiety and diabetes was found in men [24] . A further two studies found an association between generalized anxiety disorder (GAD) or GAD symptomatology with incident diabetes [25, 31] . Deschênes et al. [25] stratified their groups based on the presence of prediabetes and high anxiety symptoms measured with the GAD-7 scale at baseline. They found that people with high anxiety and prediabetes had a 10.95 times increased odds of developing diabetes over 5 years compared with people with no prediabetes and no anxiety. This association remained significant after adjustment for a range of sociodemographic, cardiometabolic, lifestyle and medication confounders [25] . However, this study also found that high anxiety symptoms in the absence of prediabetes were not associated with increased odds of developing diabetes (Table 1) . Scherrer et al. [31] , using data from a Veteran's database, found that doctor-diagnosed GAD at baseline was associated with a 1.07 times increased hazard of developing incident diabetes over 6 years. This association remained significant after adjustment, however the authors only adjusted for BMI and age [31] .
Of the four studies that examined the association between PTSD and incident anxiety [23, [30] [31] [32] , three found a [31] found that veterans with doctor-diagnosed PTSD at baseline had a 1.25 times increased hazard of developing incident diabetes, an association that remained significant after adjustment for BMI and age. Boyko et al. [23] examined PTSD in a military population using a validated scale and found those endorsing PTSD symptoms had a 2.56 times increased odds of developing incident diabetes over 3 years, an association that remained significant after adjustment for sociodemographics and BMI. They also found that panic and other anxiety also predicted incident diabetes. Miller-Archie et al. [30] examined symptoms of PTSD in people exposed to a traumatic event and found that high baseline PTSD symptoms were associated with a 1.73 times increased odds of developing incident diabetes, an association that remained significant after controlling for sociodemographics and cardiometabolic abnormalities. One article included data from three studies conducted in healthcare professionals and found that phobic anxiety symptoms at baseline were associated with an increased hazard of developing incident diabetes over 18-20 years in all three studies [27] . However, the association in the study that only included men (Healthcare Professionals Study) was no longer significant after adjustment for confounders, whereas the two studies in women (Nurses Health Studies I and II) remained significant [27] .
Of the four studies that did not provide unadjusted or minimally adjusted estimates, three found a significant association between baseline anxiety and incident diabetes [28, 35, 36] . Chien and Lin [36] used data from a Taiwanese insurance database to determine that diagnosed anxiety disorders were associated with a 1.34 times increased risk of developing incident diabetes over 5 years after adjusting for sociodemographics. Khambaty et al. [28] measured anxiety with a short screening scale in older adults and found that after adjusting for sociodemographics, cardiometabolic characteristics and smoking, those with anxiety had a 1.36 times increased hazard of incident diabetes over 10 years. P erez-Piñar et al. [35] used read codes in a primary care database to determine that diagnosed anxiety disorders were associated with a 1.14 times increased hazard of developing diabetes over 10 years after adjusting for sociodemographics and medication.
In total, three studies indicated there was no unadjusted or minimally adjusted association between either trait anxiety with incident diabetes [22] , anxiety disorders with incident diabetes [26] or PTSD symptoms with incident diabetes [32] .
There was study heterogeneity in terms of follow-up, measurement, population and analysis (Table 1) . Study follow-up ranged between 2 years [33] and 20 years [27, 37] . Studies with a shorter range of follow-up (2-5 years) reported overall diabetes incidence rates of 0.01% to 3.5% [23, 25, 33] compared with overall diabetes incidence rates of 4.4% to 25.9% in studies with a follow-up of 10 years or more [22, 24, [26] [27] [28] 32, 35, 37] . Types of anxiety measurements included the assessment of non-specific anxiety symptoms, a composite of different anxiety disorders, PTSD, phobic anxiety symptoms, panic, GAD and/or other anxiety (Table 1) . Anxiety was determined using a variety of validated symptom scales [22] [23] [24] [25] 27, 28, 30, 33, 37] , diagnostic interviews [26, 32, 33] and examination of medical records [31, 35, 36] . Most studies examined general anxiety or defined anxiety or anxiety disorders using DSM-V criteria [22, [24] [25] [26] [27] [28] 33, 35, 37] . However, three studies included anxiety disorders as defined by DSM-IV [23, 31, 36] and two studies only provided estimates for PTSD [30, 32] . All studies excluded people with diagnosed diabetes at baseline. Four studies also excluded people with high levels of blood glucose t baseline and assessed incident diabetes using blood glucose levels [22, 28, 33, 37] . One study also explicitly accounted for prediabetes in their analysis [25] . The remaining nine studies relied on self-report or medical records, and therefore undiagnosed diabetes could be an issue with these studies (Table 1) . Notably, most incident cases included in this direction of causality would have assessed incident Type 2 diabetes as studies were conducted in adult populations (Table 1) .
There were also differences in the populations studied (Table 1) . Three studies were conducted in veteran or military populations [23, 31, 32] , one study examined healthcare professionals [27] , one study was conducted in people exposed to the 9/11 attacks in New York [30] , two studies sampled people from a health insurance database [36, 37] , two studies sampled people from primary care [28, 35] , one study sampled a mixture of clinical and community populations [33] and the remaining four studies were sampled from the community [22, [24] [25] [26] . Furthermore, two studies oversampled people on the basis of anxiety and/or depression at baseline [25, 33] .
Finally, there were differences in the analyses employed by researchers, with six studies calculating ORs, two studies calculating risk ratios (RRs) and six studies calculating hazards ratios (HRs) ( Table 1) . Furthermore, one study did not control for any confounders [33] , one study only controlled for age and BMI [31] and one study only controlled for sociodemographic confounders [36] , whereas most studies controlled for a range of sociodemographic, cardiometabolic and other confounders [22, [24] [25] [26] [27] [28] 30, 32, 37] .
Diabetes to incident anxiety
Only two studies examined the association between diabetes and incident anxiety (Table 1) . Both studies had moderate to serious quality issues ( Table 2 ). The first study by Engum et al. [34] found no association between either Type 1 or Type 2 diabetes and incident anxiety symptoms over 10 years in a Norwegian population sample. Although the study included a large and representative sample, they used a different measure for anxiety at baseline and follow-up, thereby limiting inferences about incidence ( Table 1 ). The second study by Marrie et al. [29] provided only fully adjusted estimates and found no association between diabetes and incident anxiety in an administrative database over 10 years of follow-up. However, generalizability was limited by the fact that participants were sampled based on a diagnosis of multiple sclerosis or being a matched-control for multiple sclerosis participants. Both studies found no association from diabetes to incident anxiety, however due to study quality and generalizability, inferences are limited.
Implications of study review for meta-analysis
Because of the small number of studies for the direction of association from diabetes to incident anxiety, we could not move forward with a meta-analysis for this direction. However, we had sufficient data to examine the direction of association from anxiety to incident diabetes. Owing to differences in analysis (Table 1) we opted to combine all studies for a least adjusted estimate using ORs or raw event data (either calculated from data provided in the paper or by contacting study authors) that were then converted to ORs (Table S3) . Furthermore, as one paper had analysed results from three studies separately [27] , we opted to enter each study independently into the meta-analysis. Owing to study heterogeneity, we then ran a series of sensitivity analyses on our results to determine whether those sources of heterogeneity we identified in our review would have any impact on the combined estimate. We opted to run a series of analyses stratified by definition of anxiety given that the current definition of anxiety disorders no longer includes disorders such as PTSD and OCD (DSM-V), which were previously classified as anxiety disorders (DSM-IV). We also examined most-adjusted data, but these analyses were stratified by the estimate provided by the authors (i.e. OR or HR).
Meta-analysis
Results from 15 studies across 13 publications were entered into a random-effects meta-analysis (Fig. 2) . Unadjusted or age-adjusted ORs and raw event data were combined (Table S3) . We were unable to access raw data for one study [37] , however all other studies were included.
The pooled OR from the 15 studies was 1.47 (1.23-1.75). However, study heterogeneity was high (I 2 = 98.13) and the funnel plot (Fig. S1 ) and Egger's test (P = 0.05) indicated the presence of publication bias. In analyses stratified by anxiety assessment type, diabetes assessment type, and most other general sensitivity analyses, the estimate mostly remained stable (Table 3) . However, there was no significant association between anxiety and incident diabetes in sensitivity analyses that combined only studies that assessed baseline diagnosed anxiety disorders (as defined by DSM-V criteria), studies that had some serious risk of bias, and studies that provided stratified estimates for men. When we examined the most adjusted associations stratified by type of analysis, all estimates indicated a significant association between baseline anxiety with incident diabetes (Table 4 ). The eight studies that calculated an adjusted HR estimate had a combined estimate of HR 1.14 (1.08-1.21) (for forest plot see Fig. S2 ). Study heterogeneity was high for these studies (I 2 = 71.94), however there was little evidence of publication bias (Egger's test, P = 0.38; see Fig. S1 for funnel plot). The five studies that calculated an adjusted OR had a combined estimate of OR 1.64 (1.13-2.39) (for forest plot see Fig. S2 ). Study heterogeneity was high (I 2 = 84.13), however Egger's test was non-significant (P = 0.20; see Fig. S1 for funnel plot). Finally, the two studies that calculated an adjusted RR had a combined estimate of RR 1.34 (1.27 1.41) (for forest plot see Fig. S2 ). Study heterogeneity was low for these studies (I 2 = 0).
We ran a series of sensitivity analyses for the HR and OR estimates ( Table 4 ). The HR estimate remained significant except when we only examined studies that had a lowmoderate risk of bias. The OR estimate was reduced to nonsignificance when we removed the largest study [23] , only assessed low-moderate quality studies, and only included studies that had controlled for a variety of sociodemographic, cardiometabolic/adiposity and lifestyle factors [25, 26] . We could not run sensitivity analyses for the risk ratio estimate as only two studies were included.
Discussion
The results from this systematic review and meta-analysis indicate that anxiety symptoms and disorders (as defined by both DSM-IV and DSM-V criteria) are associated with an increased risk of developing incident diabetes. Furthermore, our results indicate that the association between anxiety and incident diabetes persists even after adjusting for a range of sociodemographic, cardiometabolic and adiposity-related confounders. However, the two studies that examined the direction of association from diabetes to incident anxiety found no evidence of an association, although inferences are limited by the small number of studies and quality issues.
Anxiety to diabetes
Previous work has hypothesized that anxiety could lead to an increased risk of diabetes [19] , however, to the best of our knowledge, this is the first synthesis that confirms anxiety as a risk factor for incident diabetes.
The association between anxiety and an increased risk of incident diabetes is likely due to a nuanced and complex DSM-V anxiety disorders include: generalized anxiety disorder (GAD), panic, phobia. However, they no longer include posttraumatic stress disorder (PTSD) and obsessive-compulsive disorder (OCD) which were classified as anxiety disorders until 2013. For those studies only including DSM-V anxiety disorders or anxiety we excluded PTSD from the combined estimate for Boyko et al. [23] and excluded PTSD from the combined estimate for Scherrer et al. [31] . Anxiety disorders (DSM-V) comprises only those studies where a diagnosis of anxiety disorders as defined by DSM-V was included (thus Chien and Lin [36] were excluded as they combined PTSD and OCD in their anxiety disorder estimate). [26, 38] . Thus, it is possible that the association between anxiety and diabetes could be driven, in part, by the comorbidity of anxiety with other psychological disorders such as depression [39] . However, where studies adjusted for depression [22, 26, 32] , the inclusion of depression into the statistical model did not substantially affect estimates. Furthermore, anxiety is associated with some behavioural risk factors that are linked with diabetes risk factors such as unhealthy lifestyle [12] , sleep disturbance [13] and obesity [10] . Anxiety is also linked with various biological changes that have been shown to increase the risk of diabetes such as inflammation [40] and cardiometabolic abnormalities [11] .
Although results from this analysis do not provide us with information on how anxiety is linked with an increased risk of incident diabetes, they do indicate that anxiety is an independent risk factor for diabetes even when taking confounders into account. However, more work is needed on understanding pathways of how anxiety might lead to diabetes.
Diabetes to anxiety
Results from this review indicate that more research is needed on the direction of association from diabetes to anxiety because only two studies were eligible for inclusion in this review. Neither study that examined diabetes as a risk factor for incident anxiety identified a significant association. Despite this, other work we identified that was not eligible for inclusion in this review did indicate a possible association. Cooper et al. [41] found that young people with Type 1 diabetes (average age of 9 years at baseline) had a 2.5 times increased hazard of developing incident anxiety over 26 years. Furthermore, Huang et al. [38] found a higher annual incidence of people with diabetes being diagnosed with an anxiety disorder over 5 years using data for nearly 1 million people from a Taiwanese insurance database. However, this study was not included because the lowest baseline age was 15 years. In addition, Hasan et al. [42] The following studies calculated risk ratios: Chien and Lin [36] and Demmer et al. [24] . DSM-V anxiety disorders include: Generalized anxiety disorder (GAD), panic, phobia. However, they no longer include PTSD and OCD which were classified as anxiety disorders until 2013. DSM-IV anxiety disorders include: GAD, panic, phobia, PTSD, OCD.
found that diabetes was associated with a 2.6 times increased likelihood of having a current anxiety disorder after 6 years in Australian women (although they did not explicitly remove anxiety at baseline). This work indicates that there is a possibility that diabetes could lead to incident anxiety, although exclusion criteria for our study precluded the inclusion of many of these studies. Our work also indicates a need for more research to explicitly examine whether diabetes could lead to incident anxiety. Future work examining this direction of causation needs to be mindful of possible generalizability and bias issues. For example, ascertainment bias is more likely to be an issue with studies examining incident anxiety than incident diabetes as anxiety is more likely to have a diverse life course [43] , which could limit the likelihood of capturing an event. Furthermore, as anxiety disorder tends to occur in adolescence or early adulthood [44] the approach taken by Cooper et al. [41] following people up from a younger age may better allow us to make inferences on diabetes as a cause of incident anxiety.
Clinical implications
This work adds to the body of evidence suggesting that poor mental health is an important diabetes risk factor. Previous work has found evidence that depression [45] , PTSD [46] and stress [19] can increase a person's risk of developing diabetes. This is likely a complex association via various and likely interacting pathways. However, screening for and integrating treatment for mental illness into diabetes prevention programs could be important for helping to reduce the increasing prevalence of diabetes. Despite work from this review indicating that diabetes may not be associated with an increased risk of incident anxiety, there is still evidence that anxiety is an important comorbidity to consider in people with diabetes. Anxiety is associated with poorer outcomes in people with diabetes such as poorer glycaemic control [47] , worsened functioning [48] and increased diabetes complications [49] . As such, it is important for care providers to integrate the screening and treatment of mental health conditions such as anxiety into diabetes care [50] .
Strengths and limitations
There are limitations that must be acknowledged within this review. First, there were indications that publication bias may be an issue with this review and there was also notable theoretical and statistical heterogeneity evident. Therefore, results should be interpreted with caution. There were differences in anxiety assessment, diabetes assessment, populations studied and analyses conducted. However, we were mindful of this limitation in our presentation and analysis. We also only screened studies in French and English meaning there could also be language bias present. Furthermore, setting our inclusion age to 16 years meant that we had to exclude some studies that provided compelling evidence on the longitudinal relationship between anxiety and diabetes (e.g. Cooper et al. [41] ). In addition, there are also possibly issues with only examining anxiety 'cases'. There is a possibility that below-threshold anxiety symptoms could also lead to an increased risk of incident diabetes, however, we were unable to determine this using data from the included studies. Therefore, future work could examine how below-threshold anxiety symptoms are associated longitudinally with diabetes.
There are also limitations with examining both Type 1 and Type 2 diabetes when determining longitudinal associations between anxiety and diabetes. Those studies that examined anxiety as a cause of incident diabetes are more likely to capture people with Type 2 diabetes due to the earlier onset of Type 1 diabetes. However, those studies that examined diabetes as a cause of incident anxiety are arguably better conducted in people with Type 1 diabetes as they could be followed up from a younger age allowing us to better capture first cases of anxiety. It is feasible that the best way to determine causality between diabetes and anxiety would be to take a life course approach to determine the incidence of anxiety and/or diabetes while taking the date of diabetes diagnosis into account. Future work could also stratify analyses by diabetes type.
However, despite these limitations there are several strengths to the present review. To the best of our knowledge, this is the first synthesis to systematically investigate the longitudinal association between anxiety and diabetes in a large number of databases. Furthermore, we undertook a comprehensive quality assessment and heterogeneity assessments to determine the stability of estimates and potential sources of differences in results.
Conclusions
Work from this analysis indicates that anxiety may be a risk factor for incident diabetes. However, heterogeneity between studies and evidence of publication bias suggest that results should be interpreted with caution. Furthermore, there was limited evidence that investigated the direction of association from diabetes to incident anxiety indicating the need for future work to investigate this direction of causality.
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